Company Profile
HeartSciences Stock Price, News & Analysis
- Ticker:
- HSCS
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
2.64 USD (-3.65%)
Close
Last updated: July 13, 2026 at 00:00
9.02M USD
Market cap
Why the stock is moving
HSCS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
HeartSciences is a cardiometabolic biopharmaceutical company focused on long-duration disease areas where efficacy, access, and long-term adoption all matter to investors.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, HeartSciences is followed within the cardiometabolic universe for its exposure to chronic-disease treatment demand.
Business Model Characteristics
HeartSciences follows a pipeline-and-launch model where clinical data, label expansion, and the commercial path for chronic-disease programs all shape the story.
Position Within the Biotechnology Landscape
Compared with acute-catalyst biotech names, HeartSciences sits in a more adoption-driven part of the landscape where commercial execution and follow-on data matter together.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of HeartSciences (HSCS)?
HeartSciences (HSCS) most recently closed at 2.64 USD, a -3.65% move versus the previous session.
What is the market cap of HeartSciences (HSCS)?
HeartSciences currently has a market capitalization of 9.02M USD on BioPharmSignal.
What does HeartSciences do?
HeartSciences is a cardiometabolic biopharmaceutical company focused on long-duration disease areas where efficacy, access, and long-term adoption all matter to investors.
On which exchange is HSCS stock listed?
HeartSciences (HSCS) is associated with NASDAQ, United States, Biotechnology.
What is HeartSciences?
HeartSciences is a cardiometabolic biopharmaceutical company focused on long-duration disease areas where efficacy, access, and long-term adoption all matter to investors.
Which conditions is HeartSciences targeting with HeartSciences?
HeartSciences is associated with metabolic disease based on its company overview and current catalyst commentary.